Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors
Open Access
- 1 April 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (8) , 1796-1800
- https://doi.org/10.1038/sj.bjp.0702462
Abstract
1. The receptor subtype and mechanisms underlying relaxation to adenosine were examined in human isolated small coronary arteries contracted with the thromboxane A2 mimetic, 1,5,5-hydroxy-11alpha, 9alpha-(epoxymethano)prosta-5Z, 13E-dienoic acid (U46619) to approximately 50% of their maximum contraction to K+ (125 mM) depolarization (Fmax). Relaxations were normalized as percentages of the 50% Fmax contraction. 2. Adenosine caused concentration-dependent relaxations (pEC50, 5.95+/-0.20; maximum relaxation (Rmax), 96.7+/-1.4%) that were unaffected by either combined treatment with the nitric oxide inhibitors, NG-nitro-L-arginine (L-NOARG; 100 microM) and oxyhaemoglobin (HbO; 20 microM) or the ATP-dependent K+ channel (KATP) inhibitor, glibenclamide (10 microM). The pEC50 but not Rmax to adenosine was significantly reduced by high extracellular K+ (30 mM). Relaxations to the adenylate cyclase activator, forskolin, however, were unaffected by high K+ (30 mM). 3. Adenosine and a range of adenosine analogues, adenosine, 2-chloroadenosine (2-CADO), 5'-N-ethyl-carboxamidoadenosine (NECA), R(-)-N6-(2-phenylisopropyl)-adenosine (R-PIA), S(+)-N6-(2-phenylisopropyl)-adenosine (S-PIA), N6-cyclopentyladenosine (CPA), 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-beta- D-ribofuranuronamide (IB-MECA), 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine hydrochloride (CGS 21680), relaxed arteries with a rank order of potency of NECA= 2-CADO >adenosine= IB-MECA = R-PIA= CPA > S-PIA)> CGS 21680. 4. Sensitivity but not Rmax to adenosine was significantly reduced approximately 80 and 20 fold by the non-selective adenosine receptor antagonist, 8-(p-sulphophenyl)theophylline (8-SPT) and the A2 receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX). By contrast, the A1-selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) had no effect on pEC50 or Rmax to adenosine. 5. These results suggest that A2B receptors mediate relaxation to adenosine in human small coronary arteries which is independent of NO but dependent in part on a K+-sensitive mechanism.Keywords
This publication has 32 references indexed in Scilit:
- Impact of Coronary Risk Factors on Contribution of Nitric Oxide and Adenosine to Metabolic Coronary Vasodilation in HumansJournal of the American College of Cardiology, 1998
- PROLONGED EXPOSURE TO 5′-N-ETHYLCARBOXAMIDOADENOSINE (NECA) DOES NOT AFFECT THE ADENOSINE A2A-MEDIATED VASODILATION IN PORCINE CORONARY ARTERIESPharmacological Research, 1997
- Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium‐dependent relaxation to bradykinin in human small resistance‐like coronary arteriesBritish Journal of Pharmacology, 1997
- Coronary Effects of Diadenosine Tetraphosphate Resemble Those of Adenosine in Anesthetized Pigs: Involvement of ATP-Sensitive Potassium ChannelsJournal of Cardiovascular Pharmacology, 1996
- Role of Endothelium in Hyperpolarization of Coronary Smooth Muscle by Adenosine and Its AnaloguesJournal of Cardiovascular Pharmacology, 1995
- Identification of Adenosine A2 Receptor-cAMP System in Human Aortic Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Adenosine receptor subtypesTrends in Pharmacological Sciences, 1993
- Activation of ATP-Sensitive K+ Channels by Cyclic AMP-Dependent Protein Kinase in Cultured Smooth Muscle Cells of Porcine Coronary ArteryBiochemical and Biophysical Research Communications, 1993
- THE ACETYLCHOLINE PARADOX: A CONSTRICTOR OF HUMAN SMALL CORONARY ARTERIES EVEN IN THE PRESENCE OF ENDOTHELIUMClinical and Experimental Pharmacology and Physiology, 1991
- Evidence for an A2 adenosine receptor in human coronary arteriesEuropean Journal of Pharmacology, 1988